- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Genentech MEK inhibitor
Total 110118 results
-
Genentech, Inc.Active, not recruitingBreast Cancer | Solid TumorUnited States, France, Spain, United Kingdom, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.Active, not recruitingStage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Metastatic Malignant Solid Neoplasm | Unresectable Solid Neoplasm | BRAF NP_004324.2:p.V600X | KRAS wt AlleleUnited States
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndrome (MDS)United States, Australia, Austria, Belgium, Brazil, Canada, China, Czechia, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Puerto Rico, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
Genentech, Inc.Active, not recruitingBreast CancerUnited States, Spain, Korea, Republic of, Australia, United Kingdom
-
Jeffrey ClarkeGenentech, Inc.; Duke UniversityTerminatedSmall-cell Lung Cancer | Brain MetastasesUnited States
-
Genentech, Inc.CompletedAdvanced Unresectable or Metastatic Solid MalignancyUnited States
-
Kite, A Gilead CompanyGenentech, Inc.CompletedRefractory Diffuse Large B Cell LymphomaUnited States
-
Jonsson Comprehensive Cancer CenterGenentech, Inc.CompletedGlioblastoma | Gliosarcoma | Giant Cell GlioblastomaUnited States
-
Genentech, Inc.Quotient ClinicalCompletedAmyotrophic Lateral SclerosisUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Active, not recruitingBladder Cancer | Urothelial Carcinoma | Metastatic Bladder CancerUnited States
-
Genentech, Inc.Active, not recruitingAdvanced/Metastatic TumorsSpain, United States, Korea, Republic of, Australia, France, Japan, Canada
-
Dana-Farber Cancer InstituteEli Lilly and Company; Genentech, Inc.Active, not recruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Massachusetts General HospitalNovartis; Genentech, Inc.CompletedHIV InfectionUnited States
-
Columbia UniversityGenentech, Inc.Active, not recruiting
-
Aiwu Ruth He, MDGeorgetown University; Genentech, Inc.TerminatedHepatocellular CarcinomaUnited States
-
Genentech, Inc.CompletedNeoplasms | Bladder Cancer | Solid Tumors | Biliary Cancer | Salivary CancerUnited States
-
Washington University School of MedicineGenentech, Inc.Terminated
-
Genentech, Inc.Active, not recruitingMelanomaUnited States, Germany, Australia, Korea, Republic of, Canada, Norway
-
AmgenRoche-GenentechCompletedMetastatic Colorectal Cancer | Metastatic Triple Negative Breast CancerUnited States, Belgium, Spain, Australia, Switzerland, Germany
-
Hoffmann-La RocheActive, not recruitingCancerUnited States, Canada, France, Italy, Slovenia, Spain, Turkey, United Kingdom, Argentina, Brazil, Poland, Australia, Czechia, Thailand, Korea, Republic of, Russian Federation, Switzerland, Japan, Taiwan, Austria, Hungary, Belgium, P... and more
-
Stanford UniversityGenentech, Inc.Active, not recruitingCutaneous Squamous Cell CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.; Stand Up To CancerActive, not recruitingMetastatic Prostate CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteGenentech, Inc.; ExelixisActive, not recruitingMelanoma | Skin CancerUnited States
-
Genentech, Inc.CompletedNon-Small Cell Lung CancerUnited States
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityWithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Recurrent Ovarian Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Advanced Pancreatic Carcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Recurrent... and other conditionsUnited States
-
PrECOG, LLC.Genentech, Inc.Active, not recruitingMantle Cell LymphomaUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.; Stand Up To CancerActive, not recruitingBreast Cancer | Triple Negative Breast Cancer | Circulating Tumor DNA | Residual CancerUnited States
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI); Genentech, Inc.Active, not recruitingMedulloblastomaUnited States, Canada, Australia, New Zealand
-
M.D. Anderson Cancer CenterGenentech, Inc.Active, not recruitingNon-Small Cell Lung Cancer | Lung CancerUnited States
-
University of California, San FranciscoGenentech, Inc.Active, not recruitingPediatric Recurrent/Refractory BRAFV600E-mutant GliomasUnited States, Canada
-
Howard S HochsterGenentech, Inc.; Rutgers Cancer Institute of New JerseyActive, not recruitingUnresectable Hepatocellular CarcinomaUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.Active, not recruitingTriple Negative Breast Cancer | Invasive Breast Cancer | Stage IV Breast Cancer | HER2 NegativeUnited States
-
Fox Chase Cancer CenterGenentech, Inc.Active, not recruitingHER2-positive Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of Chicago; Genentech, Inc.; Ohio State University; TargosActive, not recruitingUrothelial Carcinoma | Locally Advanced | UnresectableUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Active, not recruiting
-
Michael RothUniversity of California, Los Angeles; University of Michigan; Genentech, Inc.CompletedScleroderma, Systemic | Interstitial Lung DiseaseUnited States
-
Liza Villaruz, MDGenentech, Inc.CompletedAdvanced Non-small Cell Lung CancerUnited States
-
Columbia UniversityGenentech, Inc.; Celgene CorporationCompletedCarcinoma, Non-Small-Cell LungUnited States
-
Mylin A. Torres, MDPfizer; Genentech, Inc.; Emory UniversityTerminatedBreast Cancer | Triple Negative Breast CancerUnited States
-
Arkadiusz Z. Dudek, MDGenentech, Inc.; Vanquish Oncology, Inc.; HealthPartners Regions Cancer Care... and other collaboratorsTerminatedUveal MelanomaUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.Active, not recruiting
-
AbbVieRoche-GenentechActive, not recruitingAcute Myeloid Leukemia (AML)United States, Australia, Canada, China, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Puerto Rico, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
Dartmouth-Hitchcock Medical CenterGenentech, Inc.; Ligand PharmaceuticalsCompletedAdvanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus)United States
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Northwestern University; Dana-Farber Cancer Institute and other collaboratorsCompletedBronchioloalveolar Cell Variant of Non-small Cell Lung CancerUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.Active, not recruiting
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.; AmgenCompleted
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Genentech, Inc.CompletedNon-small Cell Lung Cancer | EGFR-mutant Lung CancersUnited States
-
Genentech, Inc.CompletedProstate CancerUnited States, Spain, Czechia, France, Greece, Netherlands, United Kingdom, Romania, Italy
-
Lawrence FongNational Cancer Institute (NCI); Genentech, Inc.; The V Foundation; Conquer Cancer... and other collaboratorsCompleted